Global Anti-Microbial Resistance 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250087

Publication Date:

June 17, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Anti-Microbial Resistance market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Antimicrobial resistance (AMR) is a global health concern characterized by the ability of microorganisms (such as bacteria, viruses, and fungi) to resist the effects of antimicrobial agents, including antibiotics and antiviral drugs. This resistance can make it difficult to treat infections and poses a significant challenge to public health.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淎nti-Microbial Resistance Industry Forecast鈥� looks at past sales and reviews total world Anti-Microbial Resistance sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Microbial Resistance sales for 2025 through 2031. With Anti-Microbial Resistance sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Microbial Resistance industry.
This Insight Report provides a comprehensive analysis of the global Anti-Microbial Resistance landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-Microbial Resistance portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Anti-Microbial Resistance market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Microbial Resistance and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Microbial Resistance.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Microbial Resistance market by product type, application, key players and key regions and countries.
Segmentation by Type:
Microbiology Culture
Immunoassay
PCR
NGS
Segmentation by Application:
Hospitals
Specialty Clinics
Diagnostic Centers
Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Accelerate Diagnostics
ADT Biotech
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Binx Health

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Anti-Microbial Resistance 麻豆原创 Size (2020-2031)
2.1.2 Anti-Microbial Resistance 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Anti-Microbial Resistance by Country/Region (2020, 2024 & 2031)
2.2 Anti-Microbial Resistance Segment by Type
2.2.1 Microbiology Culture
2.2.2 Immunoassay
2.2.3 PCR
2.2.4 NGS
2.3 Anti-Microbial Resistance 麻豆原创 Size by Type
2.3.1 Anti-Microbial Resistance 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Anti-Microbial Resistance 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Anti-Microbial Resistance Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Diagnostic Centers
2.4.4 Research Institute
2.4.5 Others
2.5 Anti-Microbial Resistance 麻豆原创 Size by Application
2.5.1 Anti-Microbial Resistance 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Anti-Microbial Resistance 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Anti-Microbial Resistance 麻豆原创 Size by Player
3.1 Anti-Microbial Resistance 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Anti-Microbial Resistance Revenue by Player (2020-2025)
3.1.2 Global Anti-Microbial Resistance Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Anti-Microbial Resistance Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-Microbial Resistance by Region
4.1 Anti-Microbial Resistance 麻豆原创 Size by Region (2020-2025)
4.2 Global Anti-Microbial Resistance Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Microbial Resistance 麻豆原创 Size Growth (2020-2025)
4.4 APAC Anti-Microbial Resistance 麻豆原创 Size Growth (2020-2025)
4.5 Europe Anti-Microbial Resistance 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Anti-Microbial Resistance 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Anti-Microbial Resistance 麻豆原创 Size by Country (2020-2025)
5.2 Americas Anti-Microbial Resistance 麻豆原创 Size by Type (2020-2025)
5.3 Americas Anti-Microbial Resistance 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Microbial Resistance 麻豆原创 Size by Region (2020-2025)
6.2 APAC Anti-Microbial Resistance 麻豆原创 Size by Type (2020-2025)
6.3 APAC Anti-Microbial Resistance 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti-Microbial Resistance 麻豆原创 Size by Country (2020-2025)
7.2 Europe Anti-Microbial Resistance 麻豆原创 Size by Type (2020-2025)
7.3 Europe Anti-Microbial Resistance 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Microbial Resistance by Region (2020-2025)
8.2 Middle East & Africa Anti-Microbial Resistance 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Anti-Microbial Resistance 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Anti-Microbial Resistance 麻豆原创 Forecast
10.1 Global Anti-Microbial Resistance Forecast by Region (2026-2031)
10.1.1 Global Anti-Microbial Resistance Forecast by Region (2026-2031)
10.1.2 Americas Anti-Microbial Resistance Forecast
10.1.3 APAC Anti-Microbial Resistance Forecast
10.1.4 Europe Anti-Microbial Resistance Forecast
10.1.5 Middle East & Africa Anti-Microbial Resistance Forecast
10.2 Americas Anti-Microbial Resistance Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Anti-Microbial Resistance Forecast
10.2.2 Canada 麻豆原创 Anti-Microbial Resistance Forecast
10.2.3 Mexico 麻豆原创 Anti-Microbial Resistance Forecast
10.2.4 Brazil 麻豆原创 Anti-Microbial Resistance Forecast
10.3 APAC Anti-Microbial Resistance Forecast by Region (2026-2031)
10.3.1 China Anti-Microbial Resistance 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Anti-Microbial Resistance Forecast
10.3.3 Korea 麻豆原创 Anti-Microbial Resistance Forecast
10.3.4 Southeast Asia 麻豆原创 Anti-Microbial Resistance Forecast
10.3.5 India 麻豆原创 Anti-Microbial Resistance Forecast
10.3.6 Australia 麻豆原创 Anti-Microbial Resistance Forecast
10.4 Europe Anti-Microbial Resistance Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Anti-Microbial Resistance Forecast
10.4.2 France 麻豆原创 Anti-Microbial Resistance Forecast
10.4.3 UK 麻豆原创 Anti-Microbial Resistance Forecast
10.4.4 Italy 麻豆原创 Anti-Microbial Resistance Forecast
10.4.5 Russia 麻豆原创 Anti-Microbial Resistance Forecast
10.5 Middle East & Africa Anti-Microbial Resistance Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Anti-Microbial Resistance Forecast
10.5.2 South Africa 麻豆原创 Anti-Microbial Resistance Forecast
10.5.3 Israel 麻豆原创 Anti-Microbial Resistance Forecast
10.5.4 Turkey 麻豆原创 Anti-Microbial Resistance Forecast
10.6 Global Anti-Microbial Resistance Forecast by Type (2026-2031)
10.7 Global Anti-Microbial Resistance Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Anti-Microbial Resistance Forecast
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Anti-Microbial Resistance Product Offered
11.1.3 Abbott Laboratories Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Information
11.2.2 Accelerate Diagnostics Anti-Microbial Resistance Product Offered
11.2.3 Accelerate Diagnostics Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Accelerate Diagnostics Main Business Overview
11.2.5 Accelerate Diagnostics Latest Developments
11.3 ADT Biotech
11.3.1 ADT Biotech Company Information
11.3.2 ADT Biotech Anti-Microbial Resistance Product Offered
11.3.3 ADT Biotech Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 ADT Biotech Main Business Overview
11.3.5 ADT Biotech Latest Developments
11.4 Beckman Coulter Diagnostics
11.4.1 Beckman Coulter Diagnostics Company Information
11.4.2 Beckman Coulter Diagnostics Anti-Microbial Resistance Product Offered
11.4.3 Beckman Coulter Diagnostics Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Beckman Coulter Diagnostics Main Business Overview
11.4.5 Beckman Coulter Diagnostics Latest Developments
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Information
11.5.2 Becton, Dickinson and Company Anti-Microbial Resistance Product Offered
11.5.3 Becton, Dickinson and Company Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Becton, Dickinson and Company Main Business Overview
11.5.5 Becton, Dickinson and Company Latest Developments
11.6 Binx Health
11.6.1 Binx Health Company Information
11.6.2 Binx Health Anti-Microbial Resistance Product Offered
11.6.3 Binx Health Anti-Microbial Resistance Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Binx Health Main Business Overview
11.6.5 Binx Health Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.